vs
Immunovant, Inc.（IMVT）与VerifyMe, Inc.（VRME）财务数据对比。点击上方公司名可切换其他公司
Immunovant, Inc.的季度营收约是VerifyMe, Inc.的1.7倍（$8.4M vs $5.0M），VerifyMe, Inc.净利率更高（-66.7% vs -899.0%，领先832.3%），Immunovant, Inc.同比增速更快（140.7% vs -7.4%）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
VerifyMe, Inc.是一家专注于身份核验、防伪溯源及品牌保护服务的科技企业，为消费品、制药、零售等行业客户提供安全认证工具、全链路溯源系统与用户互动解决方案，业务覆盖北美及多个海外市场。
IMVT vs VRME — 直观对比
营收规模更大
IMVT
是对方的1.7倍
$5.0M
营收增速更快
IMVT
高出148.1%
-7.4%
净利率更高
VRME
高出832.3%
-899.0%
损益表 — Q4 FY2024 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $5.0M |
| 净利润 | $-75.3M | $-3.4M |
| 毛利率 | — | 41.2% |
| 营业利润率 | -896.2% | -68.2% |
| 净利率 | -899.0% | -66.7% |
| 营收同比 | 140.7% | -7.4% |
| 净利润同比 | -26.7% | -38.4% |
| 每股收益（稀释后） | $-0.50 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTVRME
| Q3 25 | — | $5.0M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | $8.4M | $5.8M | ||
| Q4 23 | $8.9M | $8.7M | ||
| Q3 23 | $3.6M | $5.6M |
净利润IMVTVRME
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $-291.0K | ||
| Q1 25 | — | $-571.0K | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | — | $-346.0K | ||
| Q1 24 | $-75.3M | $-553.0K | ||
| Q4 23 | $-51.4M | $2.0K | ||
| Q3 23 | $-58.7M | $-930.0K |
毛利率IMVTVRME
| Q3 25 | — | 41.2% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | — | 33.4% | ||
| Q3 24 | — | 34.9% | ||
| Q2 24 | — | 39.1% | ||
| Q1 24 | — | 39.2% | ||
| Q4 23 | — | 33.0% | ||
| Q3 23 | — | 36.5% |
营业利润率IMVTVRME
| Q3 25 | — | -68.2% | ||
| Q2 25 | — | -7.1% | ||
| Q1 25 | — | -13.3% | ||
| Q3 24 | — | -52.8% | ||
| Q2 24 | — | -10.0% | ||
| Q1 24 | -896.2% | -11.2% | ||
| Q4 23 | -576.8% | 0.8% | ||
| Q3 23 | -1629.6% | -15.3% |
净利率IMVTVRME
| Q3 25 | — | -66.7% | ||
| Q2 25 | — | -6.4% | ||
| Q1 25 | — | -12.8% | ||
| Q3 24 | — | -44.6% | ||
| Q2 24 | — | -6.5% | ||
| Q1 24 | -899.0% | -9.6% | ||
| Q4 23 | -575.6% | 0.0% | ||
| Q3 23 | -1642.3% | -16.6% |
每股收益（稀释后）IMVTVRME
| Q3 25 | — | $-0.26 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | — | $-0.05 | ||
| Q3 24 | — | $-0.23 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | $-0.50 | $-0.05 | ||
| Q4 23 | $-0.36 | $0.00 | ||
| Q3 23 | $-0.45 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $11.1M |
| 总资产 | $666.4M | $13.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | $635.4M | $2.8M | ||
| Q4 23 | $690.9M | $3.0M | ||
| Q3 23 | $269.9M | $2.9M |
总债务IMVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $500.0K | ||
| Q2 24 | — | $600.0K | ||
| Q1 24 | — | $800.0K | ||
| Q4 23 | — | $875.0K | ||
| Q3 23 | — | $1.0M |
股东权益IMVTVRME
| Q3 25 | — | $11.1M | ||
| Q2 25 | — | $14.4M | ||
| Q1 25 | — | $14.6M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $12.3M | ||
| Q1 24 | $617.8M | $12.4M | ||
| Q4 23 | $679.3M | — | ||
| Q3 23 | $251.8M | $11.9M |
总资产IMVTVRME
| Q3 25 | — | $13.3M | ||
| Q2 25 | — | $17.2M | ||
| Q1 25 | — | $17.1M | ||
| Q3 24 | — | $14.8M | ||
| Q2 24 | — | $17.5M | ||
| Q1 24 | $666.4M | $17.9M | ||
| Q4 23 | $711.4M | $20.7M | ||
| Q3 23 | $292.1M | $18.8M |
负债/权益比IMVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.06× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $243.0K |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | — |
| 自由现金流率自由现金流/营收 | -714.4% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-214.6M | — |
8季度趋势，按日历期对齐
经营现金流IMVTVRME
| Q3 25 | — | $243.0K | ||
| Q2 25 | — | $710.0K | ||
| Q1 25 | — | $-404.0K | ||
| Q3 24 | — | $-10.0K | ||
| Q2 24 | — | $372.0K | ||
| Q1 24 | $-59.7M | $-60.0K | ||
| Q4 23 | $-47.1M | $843.0K | ||
| Q3 23 | $-60.1M | $-136.0K |
自由现金流IMVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-12.0K | ||
| Q2 24 | — | $369.0K | ||
| Q1 24 | $-59.8M | $-62.0K | ||
| Q4 23 | $-47.2M | $840.0K | ||
| Q3 23 | $-60.1M | — |
自由现金流率IMVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | -0.2% | ||
| Q2 24 | — | 6.9% | ||
| Q1 24 | -714.4% | -1.1% | ||
| Q4 23 | -528.7% | 9.6% | ||
| Q3 23 | -1682.4% | — |
资本支出强度IMVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 1.8% | 0.0% | ||
| Q4 23 | 1.5% | 0.0% | ||
| Q3 23 | 1.0% | 0.0% |
现金转化率IMVTVRME
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 421.50× | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMVT
暂无分部数据
VRME
| Proactive Services | $4.2M | 83% |
| Other | $869.0K | 17% |
